IP Library Granted Patent US 7,649,092
Granted Patent B2
US 7,649,092 · App. 12/111,131 · Granted Jan 19, 2010

Urea derivatives as calcium channel blockers

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,649,092
App. No.
12/111,131
Granted
Jan 19, 2010
Kind
B2
Abstract

Urea derivatives which comprise piperidine or piperazine rings and further substitution are effective in ameliorating conditions characterized by unwanted calcium ion channel activity.

Claims (32)

1. A compound of the formula:

and salts thereof,

wherein A is benzene;

B is piperidine;

R 1 is H or alkyl (1-8C), alkenyl (2-8C) or alkynyl (2-8C);

Z is N;

each R 3 is independently a substituent selected from the group consisting of ═O, alkyl (1-8C), alkenyl (2-8C), alkynyl (2-8C), acyl, aryl, alkylaryl, halo, CHF 2 , CF 3 , OCF 3 , OCHF 2 , OCOR, CN, NO 2 , NR 2 , OR, SR, COR, COOR, CONR 2 , SOR, SO 2 R, SO 3 R, NRCOR, NRCOOR, OCONR 2 , SONR, SO 2 NR, OOCR, NRSOR and NRSO 2 R, wherein R is H or alkyl (1-8C), alkenyl (2-8C), alkynyl (2-8C), aryl, or alkylaryl, wherein two R on the same nitrogen may form a 5-7 membered ring, and wherein two substituents on adjacent carbons may form a 5-7 membered ring;

wherein each R 4 is independently H or alkyl (1-4C);

m is 0-3;

n is 0-2;

each Ar is phenyl; and

wherein each A or B and each Ar moiety in formula (1) may be substituted by one or more substituents selected from the group consisting of ═O (in nonaromatic cyclic moieties), alkyl (1-8C), alkenyl (2-8C), alkynyl (2-8C), acyl, aryl, alkylaryl, halo, CHF 2 , CF 3 , OCF 3 , OCHF 2 , OCOR, CN, NO 2 , NR 2 , OR, SR, COR, COOR, CONR 2 , SOR, SO 2 R, SO 3 R, NRCOR, NRCOOR, OCONR 2 , SONR, SO 2 NR, OOCR, NRSOR and NRSO 2 R, wherein R is H or alkyl (1-8C), alkenyl (2-8C), alkynyl (2-8C), aryl, or alkylaryl, wherein two R on the same nitrogen may form a 5-7 membered ring, and wherein two substituents on adjacent carbons may form a 5-7 membered ring, and

wherein any alkyl, alkenyl, alkynyl or aryl set forth above may further be substituted by ═O, alkyl (1-8C), alkenyl (2-8C), alkynyl (2-8C), acyl, aryl, alkylaryl, halo, CHF 2 , CF 3 , OCF 3 , OCHF 2 , OCOR, CN, NO 2 , NR 2 , OR, SR, COR, COOR, CONR 2 , SOR, SO 2 R, SO 3 R, NRCOR, NROR, NRCOOR, OCONR 2 , SONR, SO 2 NR, OOCR, NRSOR and NRSO 2 R, wherein R is H or alkyl (1-8C), alkenyl (2-8C), alkynyl (2-8C), aryl, or alkylaryl, wherein two R on the same nitrogen may form a 5-7 membered ring, and wherein two substituents on adjacent carbons may form a 5-7 membered.

2. The compound of claim 1 , wherein R 1 is H.

3. The compound of claim 1 , wherein n is 0.

4. The compound of claim 1 , wherein m is 0.

5. The compound of claim 1 , wherein n is 2 and R 3 is ═O or COOH.

6. The compound of claim 1 , wherein each R 4 is H.

7. The compound of claim 1 , which is

4-[(1-methyl-piperidin-4-yl)-phenyl-methyl]-piperazine-1-carboxylic acid benzhydryl-amide;

4-[(1-methyl-piperidin-3-yl)-phenyl-methyl]-piperazine-1-carboxylic acid benzhydryl-amide;

4-[(1-methyl-piperidin-4-yl)-(4-fluoro-phenyl)-methyl]-piperazine-1-carboxylic acid benzhydryl-amide;

4-[(1-methyl-piperidin-4-yl)-(4-chloro-phenyl)-methyl]- piperazine-1-carboxylic acid benzhydryl-amide;

4-[(1-benzyl-piperidin-4-yl)-phenyl-methyl]-piperazine-1-carboxylic acid benzhydryl-amide;

4-[piperidin-4-yl-phenyl-methyl]-piperazine-1-carboxylic acid benzhydryl-amide;

4-[(1-methyl-piperidin-4-yl)-(2,4-dimethyl-phenyl)-methyl]-piperazine-1-carboxylic acid benzhydryl-amide;

4-[(1-methyl-piperidin-4-yl)-(2-chloro-phenyl)-methyl]-piperazine-1-carboxylic acid benzhydryl-amide;

4-[(1-methyl-piperidin-4-yl)-(3-chloro-phenyl)-methyl]-piperazine-1-carboxylic acid benzhydryl-amide;

4-(diphenyl-methyl)-piperazine-1-carboxylic acid benzhydryl-methyl-amide; or

4-[methyl-(1-methyl-piperidin-4-yl)- phenyl-methyl]-piperazine-1-carboxylic acid benzhydryl-amide, or

a salt thereof.

8. The compound of claim 1 which is coupled to polyethylene glycol.

Assignments (3)
CHANGE OF NAME Recorded Sep 15, 2010
From: NEUROMED PHARMACEUTICALS LTD.
To: ZALICUS PHARMACEUTICALS LTD.
Reel/Frame 024990/0430 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 11, 2008
From: PAJOUHESH, HASSAN; PAJOUHESH, HOSSEIN; DING, YANBING; SNUTCH, TERRANCE P.
To: NEUROMED TECHNOLOGIES INC.
Reel/Frame 021228/0017 →
CHANGE OF NAME Recorded Jul 11, 2008
From: NEUROMED TECHNOLOGIES INC.
To: NEUROMED PHARMACEUTICALS LTD.
Reel/Frame 021228/0064 →